Research suggests that the combination of curcumin (the active compound in turmeric) and piperine (from black pepper) may offer synergistic anti-inflammatory and bone-related benefits, with the available evidence generally pointing in a supportive direction. The current body of evidence consists of a 2022 review paper and a 2015 laboratory study, both of which are relatively early-stage forms of evidence rather than clinical trials conducted in humans. The review highlights that piperine appears to meaningfully improve curcumin's poor oral bioavailability by influencing how the body metabolizes the compound, which is considered a key barrier to curcumin's effectiveness, while the laboratory study found that the combination at non-toxic concentrations could suppress the activity of cells involved in bone breakdown. However, both studies acknowledge that substantially more research — particularly well-designed human clinical trials — is needed before firm conclusions can be drawn about the combination's real-world effectiveness and safety.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| A Unifying Perspective in Blunting the Limited Oral Bioavailability of Curcum... | Review | 2022 | Supports | 100 |
| Curcumin in Combination with Piperine Suppresses Osteoclastogenesis In Vitro. | Other | 2015 | Supports | 95 |